Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers ugly split with Wegovy maker weighs on the telehealth companys future

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership…

Hims & Hers ugly split with Wegovy maker weighs on the telehealth companys future

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership…

Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by…

Novo Nordisk partners with WeightWatchers after Hims & Hers fallout

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging…

Robinhood-Gold-Macherin wird CPO bei Hims

Aktie springt um über 20?%: Dheerja Kaur wird erste Chief Product Officer bei Hims Ex-Robinhood-Managerin soll Plattformwachstum mit KI,…

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman

/PRNewswire/ -- On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE:…

Jim Cramer on Hims & Hers: “You Gotta Generate Some Discipline Here”

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 14 stocks Jim Cramer recently shared insights on. Discussing the…

HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims &…

Why Is Hims & Hers Health (HIMS) Stock Soaring Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the companys CEO stated…

HIMS BREAKING NEWS: A Class Action Lawsuit has been filed against Hims & Hers Health, Inc. -- Investors are Notified to Contact BFA Law to Potentially Recover Investment Losses

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers…

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss…

Whats Going On With Hims & Hers Health Stock Today? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a…

Hims & Hers Health (NYSE:HIMS) Faces Class Action After Partnership Termination With Novo Nordisk

Hims & Hers Health (NYSE:HIMS) has experienced a tumultuous quarter, marked by Novo Nordisks termination of their collaboration after allegations…

WeightWatchers Customers Now Have Access to Wegovy at a Cheaper Price

Novo Nordisk A/S added a deal with WeightWatchers to boost access to its Wegovy obesity drug, just days after axing…

Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action

Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class…

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Hims & Hers Health (HIMS) as it is technically in oversold territory…

Hims & Hers appoints former Robinhood exec Dheerja Kaur as first CPO By Investing.com

Hims & Hers appoints former Robinhood exec Dheerja Kaur as first CPO…

Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of…

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Hims & Hers Health (HIMS) as it is technically in oversold territory…

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Hims & Hers Health (HIMS) as it is technically in oversold territory…

Welcoming Dheerja Kaur, our first Chief Product Officer

Hims & Hers welcomes Dheerja Kaur as its first Chief Product Officer to lead the next generation of personalized healthcare…

Hims & Hers: Die Anti-Establishment-Aktie mit Kultpotenzial!

In den letzten Jahren war Hims & Hers geradezu ein Paradebeispiel für eine "Buy the Dip"-Aktie: Auf jeden Rücksetzer folgte früher…

Hims & Hers will trotz Trennung von Novo Nordisk weiter günstige Abnehmspritzen verkaufen

Hims & Hers Health will trotz des überraschenden Ausstiegs von Novo Nordisk an seinem umstrittenen Geschäft mit günstigen Semaglutid-Injektionen festhalten.…

Why Hims & Hers stock may be stronger after Novo Nordisk breakup

An analyst said that Hims’ (HIMS) breakup with Novo Nordisk (NVO) isn’t as bad as it appears.…

HIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit

SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…

HIMS & HERS HEALTH, INC. (NYSE: HIMS) INVESTOR ALERT: Investors With Large Losses in Hims & Hers Health, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

HIMS & HERS HEALTH, INC. (NYSE: HIMS) INVESTOR ALERT: Investors With Large Losses in Hims & Hers Health, Inc. Should…

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy– Hagens Berman

HIMS Investors with Losses Encouraged to Contact Hagens Berman...…

Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses; August 25, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June…

Marketing Daily - Top of the News: Novo Nordisk, Hims & Hers Deal Ends

The pharma company in April said it would offer Wegovy through several telehealth companies such as Hims & Hers to…

Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman

/PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their…

Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman

SAN FRANCISCO, June 25, 2025 /PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS)…

Hims & Hers Health CEO says compounding Novo weight-loss drug will continue

Hims & Hers Health CEO Andrew Dudum said that the telehealth platform will continue to sell a compounded version of…

Hims & Hers CEO hits Novo Nordisk after breakup over knockoff Wegovy

CEO Andrew Dudum said Novo Nordisk had been pushing Hims & Hers to favor Wegovy over its own compounded weight…

Hims Wont Back Down From Selling Cheap Weight-Loss Shots

Hims & Hers Health CEO Andrew Dudum said the company will continue to sell cheap weight-loss shots despite Novo Nordisk…

Novo Nordisk split puts Hims & Hers future in question

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the companys potential to…

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…

Hims & Hers Stock: Panic Sell Or Opportunistic Buy? (NYSE:HIMS)

The breakup between Hims & Hers and Novo Nordisk has hit HIMS stock hard with a 35% crash. Click here…

Hims & Hers Health Aktie: Rechtsstreit mit Novo Nordisk bedroht Vertrauen

Charlotte, NC (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Truist: Die Analysten von Truist stufen die Aktie von Hims & Hers…

HIMS & HERS HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc.

NEW YORK and NEW ORLEANS, June 24, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C.…

SHAREHOLDER ALERT: Hims & Hers Health, Inc. Sued For Securities Fraud by Block & Leviton LLP; August 25 Deadline To Seek To Serve As Lead Plaintiff

Block & Leviton LLP filed a class action lawsuit today against Hims & Hers Health Inc. (NYSE: HIMS). Investors should…

dpa-AFX ProFeed